Cargando…
Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy
Recent research has contributed significantly to our understanding of the pathogenesis of acute disseminated intravascular coagulation. COVID-19 can be considered as a new underlying condition of disseminated intravascular coagulation. In this narrative review, current evidence is presented regardin...
Autor principal: | Wiedermann, Christian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604230/ https://www.ncbi.nlm.nih.gov/pubmed/36293332 http://dx.doi.org/10.3390/ijms232012474 |
Ejemplares similares
-
Diagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2019) -
Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: Iba, Toshiaki, et al.
Publicado: (2019) -
Use of antithrombin III in cancer patients with sepsis complicated with disseminated intravascular coagulopathy
por: Polansky, M, et al.
Publicado: (1998) -
Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: D’Amico, Ramona, et al.
Publicado: (2021) -
COVID-19 coagulopathy: is it disseminated intravascular coagulation?
por: Levi, Marcel, et al.
Publicado: (2020)